Cancer Care Ontario | Cancer Care Ontario

89 Results

Guidelines and Advice

The Treatment of Locally Advanced Pancreatic Cancer

Status: Archived
ID: 2-7
Version: 2

Jan 2016

Guidelines and Advice

Preoperative or Postoperative Therapy for Resectable Esophageal Cancer

Status: In-Review
ID: 2-11
Version: 4

Jun 2016

Guidelines and Advice

The Use of Chemotherapy and Growth Factors in Older Patients with Newly Diagnosed, Advanced Stage, Aggressive Histology Non-Hodgkin's Lymphoma

Status: Education and Information
ID: 6-7 Version 2
Version: 2

Jun 2013

Guidelines and Advice

Altered Fractionation of Radical Radiation Therapy in the Management of Unresectable Non-Small Cell Lung Cancer

Status: Education and Information
ID: 7-12 Version 2
Version: 2

May 2013

Guidelines and Advice

Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-Based Chemotherapy and Radiation

Status: In-Review
ID: 4-5

Jun 2016

Guidelines and Advice

The Prognostic Value of the DNMT3A Biomarker in Cytogenetically Normal Patients with Acute Myeloid Leukemia

Status: Archived
ID: MOAC 1

Nov 2013

Guidelines and Advice

Stem Cell Transplantation in the Treatment of Acute Lymphoblastic Leukemia: Recommendations

Status: In-Review
ID: SCT 6

Feb 2016

Guidelines and Advice

Extra-corporeal Photopheresis in the Management of Graft-Versus-Host Disease in Patients who Have Received Allogeneic Blood or Bone Marrow Transplants: Recommendations

Status: Current
ID: SCT 5

Aug 2013

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July 2011 to June 2012

Status: Current
ID: PET 2012-1

Sep 2013

Guidelines and Advice

The Role of Octreotide in the Management of Patients with Cancer

Status: Archived
ID: 12-7

Jun 2013

Guidelines and Advice

The Role of Colony-Stimulating Factor (CSF) in Patients Receiving Myelosuppressive Chemotherapy for the Treatment of Cancer

Status: Archived
ID: 12-2 Version 2.2003
Version: 2

May 2013

Guidelines and Advice

Screening High-Risk Populations for Lung Cancer

Status: Archived
ID: 15-10

Apr 2013

The Treatment of Locally Advanced Pancreatic Cancer

Preoperative or Postoperative Therapy for Resectable Esophageal Cancer

The Use of Chemotherapy and Growth Factors in Older Patients with Newly Diagnosed, Advanced Stage, Aggressive Histology Non-Hodgkin's Lymphoma

Altered Fractionation of Radical Radiation Therapy in the Management of Unresectable Non-Small Cell Lung Cancer

Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-Based Chemotherapy and Radiation

The Prognostic Value of the DNMT3A Biomarker in Cytogenetically Normal Patients with Acute Myeloid Leukemia

Stem Cell Transplantation in the Treatment of Acute Lymphoblastic Leukemia: Recommendations

Extra-corporeal Photopheresis in the Management of Graft-Versus-Host Disease in Patients who Have Received Allogeneic Blood or Bone Marrow Transplants: Recommendations

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July 2011 to June 2012

The Role of Octreotide in the Management of Patients with Cancer

The Role of Colony-Stimulating Factor (CSF) in Patients Receiving Myelosuppressive Chemotherapy for the Treatment of Cancer

Screening High-Risk Populations for Lung Cancer

Pages